Modeling an approach to define sensitivity of viral detection in sample matrices-examples with microarray readout.

Area of Science:

• Biotechnology
• Pharmaceutical Manufacturing
• Virology

Background:

• Biological medicines require stringent viral safety testing.
• Existing viral detection methods may lack the sensitivity or speed needed for modern production.
• Standardized protocols are crucial for implementing advanced detection technologies in regulated settings.

Purpose of the Study:

• To establish a robust workflow for evaluating advanced nucleic-acid-based viral detection systems.
• To assess critical performance characteristics like sensitivity, breadth of detection, and consistency.
• To guide the adoption of novel viral detection technologies in pharmaceutical manufacturing.

Main Methods:

• Developed a workflow involving challenge virus selection, preparation, and characterization.
• Integrated sample preparation and advanced detection readout for quantitative recovery assessment.
• Applied the workflow to a novel microarray-based viral detection system.

Main Results:

• The proposed workflow effectively evaluates the suitability of advanced detection systems for diverse sample matrices.
• Demonstrated the utility of the workflow in assessing a microarray-based viral detection system.
• The evaluated system showed rapid turnaround times compared to other advanced technologies.

Conclusions:

• The developed workflow provides a standardized approach for validating advanced viral detection technologies.
• This methodology aids in assessing the performance of novel systems for cell substrate and production culture characterization.
• The approach facilitates collaboration between technology users, developers, and regulators for ensuring biological product safety.